Immucell ICCC
NASDAQ ICCC
$10.44 -0.08 (-0.75%)
As of: Oct 22, 2026 · 9:45 AM EDT

Immucell (ICCC) Long-Term Investments (2014 - 2016)

Updated

Immucell's Long-Term Investments came in at $487,000 for Q2 2016, unchanged from the prior quarter.

Analysis

Immucell (ICCC) Long-Term Investments (2014 - 2016) Analysis & Trends

At the end of FY2015, Immucell's Long-Term Investments was $489,648, down 1.3% from FY2014.

  • Going back by year, Long-Term Investments was $496,000 in FY2014.
  • The five-year range for quarterly Long-Term Investments is $487,000 (Q3 2015) to $496,000 (Q4 2014).
  • Business Quant data shows ICCC's Long-Term Investments at $487,000 (Q1 2016), $489,648 (Q4 2015) and $487,000 (Q3 2015) in the three quarters before Q2 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,160.65 Bn 1,129.23 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 633.19 Bn 551.72 Bn 17.26 Bn -
3 AbbVie 501.90 Bn 475.01 Bn 12.70 Bn 266.00 Mn
4 Merck 377.07 Bn 331.45 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 302.35 Bn 266.34 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 297.00 Mn
7 Amgen 240.68 Bn 196.07 Bn 7.24 Bn -
8 Gilead Sciences 193.20 Bn 167.40 Bn 6.22 Bn -
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn 1.56 Bn
10 Immucell 94.64 Mn 72.08 Mn 2.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 487,000.00
Mar 31, 2016 487,000.00
Dec 31, 2015 489,648.00
Sep 30, 2015 487,000.00
Dec 31, 2014 496,000.00
Sep 30, 2014 496,000.00
Jun 30, 2014 496,000.00
Mar 31, 2014 496,000.00
API Access

Immucell Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ICCC&period=max&api_key=YOUR_API_KEY